Hepatic ALT Waterfall Hepatic ALT Waterfall is experimentalExperimental: a new chart, drawn from a 2025 paper; its layout and settings may still change.QualifiedValidated for regulated use. Nothing in safety.viz is, yet.ExploratoryTested and documented. Confirm every result.ExperimentalThis chartTested and documented, but what it shows or how it behaves may still change.PrototypeAn early look, on the docs site only. Not in the demo app.What each rung means
For trials that enrol participants with elevated baseline ALT but normal baseline bilirubin, where eDISH's ×ULN quadrants lose their meaning — a floating bar per participant from their own baseline ALT to their maximum on-treatment ALT in absolute U/L, ranked by baseline so the two arms' highest baselines meet at the seam, blue for placebo and bronze for active drug with new-onset jaundice in green, flanked by a box-and-whisker summary per arm (Amirzadegan et al., Drug Safety 2025, Figure 5).
This live demo mounts the committed dist/safety.viz-1.11.0 IIFE bundle — the same asset gsm.safety vendors — against real example data (adbds-abnbl.csv, built from the pharmaverseadam CDISC Pilot 01 ADaM datasets), with the full control panel active.